Epiphyseal enlargement is seen in – a) Ricketsb) Scurvyc) Spondylo-epiphyseal dysgenesisd) Juvenile rheumatoid arthritis
**Core Concept**
Epiphyseal enlargement is a characteristic feature of certain growth disorders and diseases, particularly those affecting bone development and mineralization. This phenomenon is often observed in conditions that lead to abnormal bone growth, remodeling, or mineralization.
**Why the Correct Answer is Right**
Epiphyseal enlargement is indeed seen in juvenile rheumatoid arthritis (JRA), also known as juvenile idiopathic arthritis (JIA). This condition is a chronic autoimmune inflammatory disease that affects the joints, leading to synovial inflammation and subsequent bone growth abnormalities. The epiphyseal enlargement in JRA is a result of the chronic inflammation and subsequent activation of growth factors, which stimulate excessive bone growth and remodeling. The growth plates become widened and irregular, leading to characteristic epiphyseal enlargement.
**Why Each Wrong Option is Incorrect**
**Option A:** Rickets is a condition caused by vitamin D deficiency, leading to softening of the bones and skeletal deformities. While rickets does affect bone growth and mineralization, it typically results in bone softening and deformities, rather than epiphyseal enlargement.
**Option B:** Scurvy is a disease caused by vitamin C deficiency, leading to impaired collagen synthesis and connective tissue integrity. Scurvy can cause bone pain, osteoporosis, and skeletal deformities, but it is not typically associated with epiphyseal enlargement.
**Option C:** Spondylo-epiphyseal dysplasia is a rare genetic disorder affecting the spine and epiphyses. While it does affect bone growth and development, it is not typically characterized by epiphyseal enlargement.
**Clinical Pearl / High-Yield Fact**
Juvenile rheumatoid arthritis (JRA) can present with a range of clinical manifestations, including joint pain, swelling, and epiphyseal enlargement. It is essential to recognize the characteristic features of JRA, particularly in children and adolescents, to initiate timely and effective treatment.
**Correct Answer:** D. Juvenile rheumatoid arthritis.